# Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis.

> **NCT03061591** · PHASE2 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Familial Adenomatous Polyposis
- FAP
- FAP Gene Mutation

## Interventions

- **DIETARY_SUPPLEMENT:** Wholistic Turmeric capsules
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03061591
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04
- **Primary completion:** 2018-04
- **Final completion:** 2020-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03061591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03061591, "Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03061591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*